Michael Riordan

Michael Riordan is currently the Business Unit Head at Pfizer Pharmaceuticals, having developed a robust career in the oncology sector since 2009. Prior experience includes serving as the Business Unit Director for Oncology, where they managed a multi-brand franchise and led significant new medicine launches. Michael also held various roles within Pfizer, including leadership in rare diseases and inflammation, and served on the Board of Directors for Pfizer Healthcare Ireland. Michael earned a Master's degree in Business Studies, alongside a Higher Diploma in Management and Marketing, and a Bachelor of Science in Chemistry from University College Cork.